48 results
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Resistance, Main Uses ... /kg/min - Milrinone ... Properties #Table #Pharmacology ... #Effect #Management
Hypoxemic Respiratory Failure - Differential Diagnosis Framework
DECREASED INSPIRED OXYGEN
 • Low PATM Can decrease first part
High altitude (eg ... respiratory drive due to neurologic ... Intrapulmonary shunting (eg ... , pulmonary AVMs ... intracardiac shunting (eg
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
Causes of Fatigue ... Chronic Obstructive Pulmonary ... Disease Neurologic ... Myasthenia Gravis Pharmacologic ... • Drug Abuse (e.g
A practical guide to starting levothyroxine therapy
Calculate full replacement dose: 1.6 mcg/kg/day
Young, otherwise healthy patient:
 •
replacement dose: 1.6 mcg ... /kg/day Young, ... Start at 25-50 mcg ... initiation #starting #management ... endocrinology #pharmacology
Vasopressors and Inotropes - Pharmacology Summary
Vasopressors
Phenylephrine (alpha-1)
 • Increases BP, SVR
 • Risk of reflex bradycardia
and Inotropes - Pharmacology ... • Higher doses cause ... cAMP/cGMP • Causes ... Vasopressors #Inotropes #Pharmacology ... #Summary #management
Peri-operative Hyperthermia - Guidelines for Crises in Anaesthesia
If prolonged or ≥ 39 C this is a
Surgical devices, e.g ... Sepsis (→ 3-14) e.g ... malignant syndrome (e.g ... Phaeochromocytoma Neurologic ... Checklist #Diagnosis #Management
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Control rate (e.g ... Treat underlying cause ... Control rate (e.g ... Treat underlying cause ... Tachycardia #Treatment #management
Acute Respiratory Distress Syndrome – ARDS: Clinical Cheat Sheet

An acute diffuse, inflammatory lung injury, leading to
leading to increased pulmonary ... consistent with pulmonary ... objective assessment“ (e.g ... there is no clear cause ... the underlying cause
Hydroxychloroquine Serum Measurement in SLE
 • Terminal elimination half-life = 40 days ([HCQI reflects long-term intake)
suspected) • In case ... • Special cases ... (e.g. renal failure ... #rheumatology #pharmacology ... levels #lupus #management
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
Presentation - Young ... Radiographic findings (eg ... Laboratory findings (eg ... VEP’s: EEG of visual ... sclerosis #diagnosis #management